Optical coherence tomography-A new diagnostic tool to evaluate axonal degeneration in multiple sclerosis: A review

Turk Noroloji Dergisi

Volumn 16, Issue 3, 2010, Pages 121-126

  Kale, Nilüfer ^a   Eggenberger, Eric ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Multiple sclerosis; Optic neuritis; Optical coherence; Tomography

Indexed keywords

AXONAL INJURY; DEMYELINATION; ELECTROPHYSIOLOGY; GLIOSIS; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROIMAGING; NEUROPROTECTION; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSICS; PROGNOSIS; RETINA NERVE CELL; REVIEW; VISUAL SYSTEM;

EID: 78349277766     PISSN: 1301062X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17:210-8.
2. Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol 2009;31:439-53.
3. Kolappan M, Henderson AP, Jenkins TM, Wheeler-Kingshott CA, Plant GT, Thompson AJ, et al. Assessing structure and function of the afferent visual pathway in multiple sclero sis and associated optic neuritis. J Neurol 2009;256:305-19.
4. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69. (Pubitemid 27493740)
5. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
6. Whiting P, Harbord R, Main C, Deeks JJ, Filippini G, Egger M, et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ 2006;332:875-84.
7. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175-89.
8. Kallenbach K, Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol 2007;14:841-9.
9. Subei AM, Eggenberger ER. Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium. Curr Opin Ophthalmol 2009;20:462-6.
10. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130(Pt 4):1089-104.
11. Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A. OCT in MS Expert Panel. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007;263:3-14.
12. Glisson CC, Galetta SL. Nonconventional optic nerve imaging in multiple sclerosis. Neuroimaging Clin N Am 2009;19:71-9.
13. Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 2008;14:893-905.
14. Younis A, Eggenberger E. Correlation of relative afferent pupillary defect and retinal nerve fiber layer loss in unilateral or asymmetrical demyelinating optic neuropathy. Invest Ophthalmol Vis Sci 2010;51:4013-6.
15. Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, et al. Retinal architecture predicts pupillary reflex metrics in MS. Mult Scler 2009;15:479-86.
16. Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, et al. Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 2008;65:1218-22.
17. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008;131:277-87.
18. Blumenthal EZ, Parikh RS, Pe'er J, Naik M, Kaliner E, Cohen MJ, et al. Retinal nerve fibre layer imaging compared with histological measurements in a human eye. Eye 2009;23:171-5.
19. Cheung CY, Yiu CK, Weinreb RN, et al. Effects of scan circle displacement in optical coherence tomography retinal nerve fibre layer thickness measurement: a RNFL modelling study. Eye 2009;23:1436-41.
20. Cheung CY, Leung CK, Lin D, et al. Relationship between retinal nerve fiber layer measurement and signal strength in optical coherence tomography. Ophthalmology 2008;115:1347-51.
21. Savini G, Zanini M, Barboni P. Influence of pupil size and cataract on retinal nerve fiber layer thickness measurements by Stratus OCT. J Glaucoma 2006;15:336-40.
22. Youm DJ, Kim JM, Park KH, Choi CY. The effect of soft contact lenses during the measurement of retinal nerve fiber layer thickness using optical coherence tomography. Curr Eye Res 2009;34:78-83.
23. Bock M, Brandt AU, Dörr J, Kraft H, Weinges-Evers N, Gaede G, et al. Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg 2010;112:647-52.
24. Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009;282:96-105.
25. Siepman TA, Wefers M, Hintzen RQ. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry. J Neurol 2010.
26. Garcia-Martin E, Pueyo V, Martin J, et al. Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis. Eur J Ophthalmol. 2010;20:167-73.
27. Pueyo V, Ara JR, Almarcegui C, et al. Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis. Acta Ophthalmol 2009.
28. Nakamura M, Nakazawa T, Doi H, Hariya T, Omodaka K, Misu T, et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 2010.
29. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14.
30. Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 2007;64:899-901. (Pubitemid 46919849)
31. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
32. Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 1997;115:1425-8.
33. Leung CK, Cheung CY, Lin D, Pang CP, Lam DS, Weinreb RN. Longitudinal variability of optic disc and retinal nerve fiber layer measurements. Invest Ophthalmol Vis Sci 2008;49:4886-92.
34. Balcer LJ, Frohman EM. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology 2010;74(Suppl 3):S16-S23.
35. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009;5:256-66.